OTCMKTS:CPHRF Cipher Pharmaceuticals - CPHRF Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cipher Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $2.56 0.00 (0.00%) (As of 02/7/2023 12:00 AM ET) Add Compare Share Share Today's Range$2.56▼$2.6750-Day Range$2.54▼$5.3852-Week Range$1.06▼$5.38Volume2,483 shsAverage Volume7,068 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsInstitutional OwnershipHeadlinesShort Interest About Cipher Pharmaceuticals (OTCMKTS:CPHRF) StockCipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. Its products include dermatology, hospital acute care, and out-licensed products. The company was founded in 2000 and is headquartered in Oakville, Canada.Read More Receive CPHRF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cipher Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CPHRF Stock News HeadlinesJanuary 31, 2023 | finance.yahoo.comCipher Pharmaceuticals (TSE:CPH) shareholders have earned a 51% CAGR over the last three yearsJanuary 13, 2023 | finanznachrichten.deCypher Core, Inc: CIPHER-CORE, Inc. President Addresses Company's Business DirectionFebruary 7, 2023 | Wall Street Watch Dogs (Ad)The #1 Energy Stock to BuyThe next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…November 11, 2022 | ca.finance.yahoo.comCipher Pharmaceuticals Inc. (CPHRF)November 10, 2022 | finance.yahoo.comCipher Pharmaceuticals Reports Strong Third Quarter Results, Highlighted by USD$1.09 in Cash Per ShareAugust 24, 2022 | finance.yahoo.comInvesting in Cipher Pharmaceuticals (TSE:CPH) three years ago would have delivered you a 107% gainAugust 12, 2022 | seekingalpha.comCipher Pharmaceuticals Inc. (CPHRF) CEO Craig Mull on Q2 2022 Results - Earnings Call TranscriptAugust 11, 2022 | finance.yahoo.comCipher Pharmaceuticals Strengthens Leadership Team with Appointment of New CFOFebruary 7, 2023 | Wall Street Watch Dogs (Ad)The #1 Energy Stock to BuyThe next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…July 9, 2022 | theglobeandmail.comCipher Pharmaceuticals Inc stock boosted on Friday.May 14, 2022 | seekingalpha.comCipher Pharmaceuticals GAAP EPS of C$0.08, revenue of C$5.4MMarch 24, 2022 | finance.yahoo.comIs Now The Time To Put Cipher Pharmaceuticals (TSE:CPH) On Your Watchlist?March 22, 2022 | finance.yahoo.comCipher Pharmaceuticals Announces Partner, Moberg Pharma's Regulatory Submission to FDA for North American Phase 3 StudyMarch 18, 2022 | benzinga.comMariMed Doubles Full Year Revenue And Adjusted EBITDA, Reports Q4 & Full Year EarningsMarch 18, 2022 | msn.comMarijuana Stock Movers For March 16, 2022March 18, 2022 | benzinga.comResearcher Who Discovered Cannabinoid Acids May Prevent COVID-19 Infection Launches His Own CompanyMarch 13, 2022 | benzinga.comNovamind Stock Slightly Up On Grants Restricted Share UnitsMarch 11, 2022 | finance.yahoo.comCipher Pharmaceuticals Schedules Q4 2021 Earnings Release and Conference CallMarch 10, 2022 | finance.yahoo.comCipher Pharmaceuticals Announces Extension of Distribution and Supply Agreement with Sun Pharmaceutical Industries Inc.March 8, 2022 | benzinga.comThere's Never Been A Better Time To Be A Weed Edibles ChefJanuary 18, 2022 | benzinga.comInterview With Julianne Keu, Psychedelic YouTuberJanuary 17, 2022 | benzinga.comPsychedelics Can Change Your View On The Nature Of RealityJanuary 17, 2022 | finance.yahoo.comCipher Pharmaceuticals Inc. (TSE:CPH) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?January 16, 2022 | benzinga.comAvicanna To Bring Its CBD-Based Drugs To Latin America Via Chilean Pharma PartnerDecember 21, 2021 | benzinga.comGlass House Brands To Acquire California Cannabis Edibles Manufacturer For $25.6MAugust 15, 2021 | finance.yahoo.comCipher Pharmaceuticals Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This YearAugust 1, 2021 | benzinga.comAustralia Gets Psychedelics Research Institute With $29M In Funding From Undisclosed North American CompanySee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CPHRF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cipher Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CPHRF Company Calendar Last Earnings5/05/2016Today2/07/2023Next Earnings (Estimated)3/15/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CPHRF Previous SymbolNASDAQ:CPHR CUSIPN/A CIKN/A Webwww.cipherpharma.com Phone(905) 602-5840FaxN/AEmployees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesCraig MullChairman & Chief Executive OfficerBryan JacobsChief Financial OfficerDiane GajewczykVice President-Scientific & Medical AffairsJames BowenInvestor Relations ContactKey Competitors1933 IndustriesOTCMKTS:TGIFF4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFAcreageOTCMKTS:ACRHFView All Competitors CPHRF Stock - Frequently Asked Questions How have CPHRF shares performed in 2023? Cipher Pharmaceuticals' stock was trading at $2.7949 at the start of the year. Since then, CPHRF shares have decreased by 8.4% and is now trading at $2.56. View the best growth stocks for 2023 here. Are investors shorting Cipher Pharmaceuticals? Cipher Pharmaceuticals saw a decrease in short interest during the month of December. As of December 30th, there was short interest totaling 1,600 shares, a decrease of 33.3% from the December 15th total of 2,400 shares. Based on an average trading volume of 4,000 shares, the days-to-cover ratio is presently 0.4 days. View Cipher Pharmaceuticals' Short Interest. When is Cipher Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 15th 2023. View our CPHRF earnings forecast. How were Cipher Pharmaceuticals' earnings last quarter? Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) announced its quarterly earnings data on Thursday, May, 5th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $0.06. The firm earned $9.10 million during the quarter, compared to analysts' expectations of $10.87 million. What is Cipher Pharmaceuticals' stock symbol? Cipher Pharmaceuticals trades on the OTCMKTS under the ticker symbol "CPHRF." How do I buy shares of Cipher Pharmaceuticals? Shares of CPHRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cipher Pharmaceuticals' stock price today? One share of CPHRF stock can currently be purchased for approximately $2.56. How can I contact Cipher Pharmaceuticals? Cipher Pharmaceuticals' mailing address is 2345 Argentia Rd Suite 100A, MISSISSAUGA, ON L5N 8K4, Canada. The official website for the company is www.cipherpharma.com. The company can be reached via phone at (905) 602-5840. This page (OTCMKTS:CPHRF) was last updated on 2/7/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.